scispace - formally typeset
J

Jing Wang

Researcher at Sun Yat-sen University

Publications -  5000
Citations -  237773

Jing Wang is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Medicine & Large Hadron Collider. The author has an hindex of 184, co-authored 4046 publications receiving 202769 citations. Previous affiliations of Jing Wang include CERN & Yangzhou University.

Papers
More filters
Journal ArticleDOI

Observation of a new boson at a mass of 125 GeV with the CMS experiment at the LHC

S. Chatrchyan, +2863 more
- 17 Sep 2012 - 
TL;DR: In this paper, results from searches for the standard model Higgs boson in proton-proton collisions at 7 and 8 TeV in the CMS experiment at the LHC, using data samples corresponding to integrated luminosities of up to 5.8 standard deviations.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Book

The ATLAS Experiment at the CERN Large Hadron Collider

Georges Aad, +3032 more
TL;DR: The ATLAS detector as installed in its experimental cavern at point 1 at CERN is described in this paper, where a brief overview of the expected performance of the detector when the Large Hadron Collider begins operation is also presented.
Journal ArticleDOI

De novo assembly of human genomes with massively parallel short read sequencing

Ruiqiang Li, +13 more
- 01 Feb 2010 - 
TL;DR: The development of this de novo short read assembly method creates new opportunities for building reference sequences and carrying out accurate analyses of unexplored genomes in a cost-effective way.
Journal ArticleDOI

Antibody responses to SARS-CoV-2 in patients with COVID-19.

Quanxin Long, +50 more
- 29 Apr 2020 - 
TL;DR: It is suggested that SARS-CoV2-specific IgG or IgM seroconversion occurs within 20 days post symptom onset and may be helpful for the diagnosis of suspected patients with negative RT–PCR results and for the identification of asymptomatic infections.